tirzepatide bpi labs b6 tirzepatide: complete guide to quality, safety, and what researchers need to know BPI labs is challenging the – BPI Labs | 503B Compounding

The company has filed a growing list of trademark actions against parties that use its trademarks, Ozempic included, to describe compounded products not made by Novo, arguing that such references risk confusing consumers and blurring the distinction between FDA-approved drugs and compounded alternatives

In China, it is frequently used for the adjuvant treatment of type 2 diabetes, hyperlipidemia, and hypertension (2)

People with the condition face an increased risk of developing type 2 diabetes, with more than half experiencing either diabetes or prediabetes before their early 40s [6]

It also cites durability: discontinuation studies show weight regain occurs, while people who stay on treatment sustain their loss

Diarrhea occurs in 10-30 percent of users, particularly at higher doses or when starting supplementation